This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The present fourth edition of this established work continues a previous pattern of expansion by updating new approaches to ocular therapy, by describing new therapeutic agents and recognized side effects, and by providing very comprehensive lists of references. As before, the book is divided into two sections, drugs in ophthalmic practice and currently employed ophthalmic therapy.
Dr Havener writes in a free-flowing, easily readable style that is informative and uniform. The advantages of single authorship are quickly perceived, ie, good organization of material and lack of repetition and contradictions. A few minor disadvantages of single authorship are also apparent, including varying emphasis on selected current pharmacologic topics based on the author's background and interests and, at times, lack of indepth interpretation of some studies that are abstracted. Sometimes it appears that several reports are cited that are not closely related and are quite in conflict, leaving the reader uncertain as
Ellis PP. Ocular Pharmacology. Arch Ophthalmol. 1979;97(4):779. doi:10.1001/archopht.1979.01020010413038
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: